nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CYP2D6—Alzheimer's disease	0.329	1	CbGaD
Fesoterodine—CYP2D6—Rivastigmine—Alzheimer's disease	0.106	0.264	CbGbCtD
Fesoterodine—CYP2D6—Donepezil—Alzheimer's disease	0.0847	0.211	CbGbCtD
Fesoterodine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0674	0.168	CbGbCtD
Fesoterodine—CYP2D6—Galantamine—Alzheimer's disease	0.0546	0.136	CbGbCtD
Fesoterodine—CYP3A4—Donepezil—Alzheimer's disease	0.0539	0.134	CbGbCtD
Fesoterodine—CYP3A4—Galantamine—Alzheimer's disease	0.0347	0.0865	CbGbCtD
Fesoterodine—Benign prostatic hyperplasia—Rivastigmine—Alzheimer's disease	0.00839	0.042	CcSEcCtD
Fesoterodine—Irritable bowel syndrome—Donepezil—Alzheimer's disease	0.00696	0.0348	CcSEcCtD
Fesoterodine—Diverticulitis—Galantamine—Alzheimer's disease	0.00649	0.0325	CcSEcCtD
Fesoterodine—Functional gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00649	0.0325	CcSEcCtD
Fesoterodine—Diverticulitis—Donepezil—Alzheimer's disease	0.00503	0.0252	CcSEcCtD
Fesoterodine—Diverticulitis—Memantine—Alzheimer's disease	0.00457	0.0229	CcSEcCtD
Fesoterodine—Diverticulitis—Rivastigmine—Alzheimer's disease	0.00447	0.0224	CcSEcCtD
Fesoterodine—Micturition disorder—Memantine—Alzheimer's disease	0.00446	0.0223	CcSEcCtD
Fesoterodine—Micturition disorder—Rivastigmine—Alzheimer's disease	0.00436	0.0218	CcSEcCtD
Fesoterodine—Musculoskeletal disorder—Memantine—Alzheimer's disease	0.00417	0.0209	CcSEcCtD
Fesoterodine—Musculoskeletal disorder—Rivastigmine—Alzheimer's disease	0.00408	0.0204	CcSEcCtD
Fesoterodine—Hepatic enzyme increased—Galantamine—Alzheimer's disease	0.00224	0.0112	CcSEcCtD
Fesoterodine—Gamma-glutamyltransferase increased—Memantine—Alzheimer's disease	0.00181	0.00905	CcSEcCtD
Fesoterodine—Gastroenteritis—Galantamine—Alzheimer's disease	0.00173	0.00867	CcSEcCtD
Fesoterodine—Gastrooesophageal reflux disease—Memantine—Alzheimer's disease	0.00165	0.00825	CcSEcCtD
Fesoterodine—Gastrooesophageal reflux disease—Rivastigmine—Alzheimer's disease	0.00161	0.00807	CcSEcCtD
Fesoterodine—Hepatic enzyme increased—Memantine—Alzheimer's disease	0.00157	0.00788	CcSEcCtD
Fesoterodine—Dry eye—Donepezil—Alzheimer's disease	0.00151	0.00758	CcSEcCtD
Fesoterodine—Urinary retention—Galantamine—Alzheimer's disease	0.00146	0.00731	CcSEcCtD
Fesoterodine—Abdominal pain upper—Galantamine—Alzheimer's disease	0.0014	0.00702	CcSEcCtD
Fesoterodine—Gastroenteritis—Donepezil—Alzheimer's disease	0.00134	0.00672	CcSEcCtD
Fesoterodine—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00127	0.00637	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00123	0.00617	CcSEcCtD
Fesoterodine—Gastroenteritis—Memantine—Alzheimer's disease	0.00122	0.0061	CcSEcCtD
Fesoterodine—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.00119	0.00597	CcSEcCtD
Fesoterodine—Urinary tract infection—Galantamine—Alzheimer's disease	0.00115	0.00576	CcSEcCtD
Fesoterodine—Face oedema—Donepezil—Alzheimer's disease	0.00115	0.00575	CcSEcCtD
Fesoterodine—Urinary retention—Donepezil—Alzheimer's disease	0.00113	0.00566	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00112	0.0056	CcSEcCtD
Fesoterodine—CHRM4—nervous system—Alzheimer's disease	0.0011	0.0545	CbGeAlD
Fesoterodine—CHRM2—forebrain—Alzheimer's disease	0.00109	0.0538	CbGeAlD
Fesoterodine—Dry skin—Donepezil—Alzheimer's disease	0.00109	0.00546	CcSEcCtD
Fesoterodine—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00109	0.00544	CcSEcCtD
Fesoterodine—CHRM4—central nervous system—Alzheimer's disease	0.00106	0.0524	CbGeAlD
Fesoterodine—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00105	0.00525	CcSEcCtD
Fesoterodine—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00105	0.00525	CcSEcCtD
Fesoterodine—Oedema peripheral—Galantamine—Alzheimer's disease	0.00105	0.00524	CcSEcCtD
Fesoterodine—Urethral disorder—Galantamine—Alzheimer's disease	0.00104	0.00521	CcSEcCtD
Fesoterodine—Urinary retention—Memantine—Alzheimer's disease	0.00103	0.00514	CcSEcCtD
Fesoterodine—Face oedema—Rivastigmine—Alzheimer's disease	0.00102	0.00511	CcSEcCtD
Fesoterodine—Urinary retention—Rivastigmine—Alzheimer's disease	0.001	0.00503	CcSEcCtD
Fesoterodine—CHRM2—telencephalon—Alzheimer's disease	0.001	0.0495	CbGeAlD
Fesoterodine—Angina pectoris—Donepezil—Alzheimer's disease	0.001	0.00501	CcSEcCtD
Fesoterodine—CHRM1—forebrain—Alzheimer's disease	0.000994	0.049	CbGeAlD
Fesoterodine—Eye disorder—Galantamine—Alzheimer's disease	0.000993	0.00497	CcSEcCtD
Fesoterodine—Dry skin—Memantine—Alzheimer's disease	0.00099	0.00496	CcSEcCtD
Fesoterodine—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000986	0.00493	CcSEcCtD
Fesoterodine—Cardiac disorder—Galantamine—Alzheimer's disease	0.000986	0.00493	CcSEcCtD
Fesoterodine—Dry skin—Rivastigmine—Alzheimer's disease	0.000969	0.00485	CcSEcCtD
Fesoterodine—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000965	0.00483	CcSEcCtD
Fesoterodine—Dysuria—Donepezil—Alzheimer's disease	0.000962	0.00481	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000953	0.00477	CcSEcCtD
Fesoterodine—Mental disorder—Galantamine—Alzheimer's disease	0.000931	0.00466	CcSEcCtD
Fesoterodine—Infestation NOS—Donepezil—Alzheimer's disease	0.000917	0.00459	CcSEcCtD
Fesoterodine—Infestation—Donepezil—Alzheimer's disease	0.000917	0.00459	CcSEcCtD
Fesoterodine—CHRM1—telencephalon—Alzheimer's disease	0.000914	0.0451	CbGeAlD
Fesoterodine—Flatulence—Galantamine—Alzheimer's disease	0.000911	0.00456	CcSEcCtD
Fesoterodine—Angina pectoris—Memantine—Alzheimer's disease	0.00091	0.00455	CcSEcCtD
Fesoterodine—Dysgeusia—Galantamine—Alzheimer's disease	0.000905	0.00453	CcSEcCtD
Fesoterodine—Back pain—Galantamine—Alzheimer's disease	0.000894	0.00448	CcSEcCtD
Fesoterodine—Urinary tract infection—Donepezil—Alzheimer's disease	0.000891	0.00446	CcSEcCtD
Fesoterodine—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00089	0.00445	CcSEcCtD
Fesoterodine—CHRM3—forebrain—Alzheimer's disease	0.000889	0.0439	CbGeAlD
Fesoterodine—Dysuria—Memantine—Alzheimer's disease	0.000873	0.00437	CcSEcCtD
Fesoterodine—Vision blurred—Galantamine—Alzheimer's disease	0.000871	0.00436	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000868	0.00434	CcSEcCtD
Fesoterodine—CHRM5—nervous system—Alzheimer's disease	0.000864	0.0426	CbGeAlD
Fesoterodine—Dysuria—Rivastigmine—Alzheimer's disease	0.000854	0.00428	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000849	0.00425	CcSEcCtD
Fesoterodine—CHRM4—brain—Alzheimer's disease	0.000845	0.0416	CbGeAlD
Fesoterodine—Infestation—Memantine—Alzheimer's disease	0.000833	0.00417	CcSEcCtD
Fesoterodine—Infestation NOS—Memantine—Alzheimer's disease	0.000833	0.00417	CcSEcCtD
Fesoterodine—CHRM5—central nervous system—Alzheimer's disease	0.000831	0.041	CbGeAlD
Fesoterodine—Vertigo—Galantamine—Alzheimer's disease	0.000831	0.00416	CcSEcCtD
Fesoterodine—CHRM3—telencephalon—Alzheimer's disease	0.000818	0.0403	CbGeAlD
Fesoterodine—Palpitations—Galantamine—Alzheimer's disease	0.000817	0.00409	CcSEcCtD
Fesoterodine—Infestation—Rivastigmine—Alzheimer's disease	0.000814	0.00408	CcSEcCtD
Fesoterodine—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000814	0.00408	CcSEcCtD
Fesoterodine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000813	0.00407	CcSEcCtD
Fesoterodine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000811	0.00406	CcSEcCtD
Fesoterodine—Urinary tract infection—Memantine—Alzheimer's disease	0.000809	0.00405	CcSEcCtD
Fesoterodine—Urethral disorder—Donepezil—Alzheimer's disease	0.000807	0.00404	CcSEcCtD
Fesoterodine—Cough—Galantamine—Alzheimer's disease	0.000807	0.00404	CcSEcCtD
Fesoterodine—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000792	0.00396	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000787	0.00394	CcSEcCtD
Fesoterodine—Chest pain—Galantamine—Alzheimer's disease	0.000787	0.00394	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000782	0.00391	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00077	0.00386	CcSEcCtD
Fesoterodine—Dry mouth—Galantamine—Alzheimer's disease	0.00077	0.00385	CcSEcCtD
Fesoterodine—Confusional state—Galantamine—Alzheimer's disease	0.000761	0.00381	CcSEcCtD
Fesoterodine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00074	0.0037	CcSEcCtD
Fesoterodine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000738	0.00369	CcSEcCtD
Fesoterodine—Tachycardia—Galantamine—Alzheimer's disease	0.000736	0.00369	CcSEcCtD
Fesoterodine—Oedema peripheral—Memantine—Alzheimer's disease	0.000736	0.00369	CcSEcCtD
Fesoterodine—Skin disorder—Galantamine—Alzheimer's disease	0.000733	0.00367	CcSEcCtD
Fesoterodine—Urethral disorder—Memantine—Alzheimer's disease	0.000733	0.00367	CcSEcCtD
Fesoterodine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000722	0.00361	CcSEcCtD
Fesoterodine—Mental disorder—Donepezil—Alzheimer's disease	0.000721	0.00361	CcSEcCtD
Fesoterodine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00072	0.00361	CcSEcCtD
Fesoterodine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000717	0.00359	CcSEcCtD
Fesoterodine—Flatulence—Donepezil—Alzheimer's disease	0.000706	0.00353	CcSEcCtD
Fesoterodine—Dysgeusia—Donepezil—Alzheimer's disease	0.000702	0.00351	CcSEcCtD
Fesoterodine—Eye disorder—Memantine—Alzheimer's disease	0.000698	0.0035	CcSEcCtD
Fesoterodine—Cardiac disorder—Memantine—Alzheimer's disease	0.000694	0.00347	CcSEcCtD
Fesoterodine—Back pain—Donepezil—Alzheimer's disease	0.000693	0.00347	CcSEcCtD
Fesoterodine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000683	0.00342	CcSEcCtD
Fesoterodine—Insomnia—Galantamine—Alzheimer's disease	0.000683	0.00342	CcSEcCtD
Fesoterodine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000679	0.0034	CcSEcCtD
Fesoterodine—Vision blurred—Donepezil—Alzheimer's disease	0.000675	0.00338	CcSEcCtD
Fesoterodine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000674	0.00337	CcSEcCtD
Fesoterodine—Somnolence—Galantamine—Alzheimer's disease	0.000671	0.00336	CcSEcCtD
Fesoterodine—Dyspepsia—Galantamine—Alzheimer's disease	0.000664	0.00332	CcSEcCtD
Fesoterodine—CHRM5—brain—Alzheimer's disease	0.00066	0.0325	CbGeAlD
Fesoterodine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000659	0.0033	CcSEcCtD
Fesoterodine—ABCB1—blood vessel—Alzheimer's disease	0.000656	0.0323	CbGeAlD
Fesoterodine—Mental disorder—Memantine—Alzheimer's disease	0.000655	0.00328	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000651	0.00326	CcSEcCtD
Fesoterodine—Fatigue—Galantamine—Alzheimer's disease	0.000651	0.00326	CcSEcCtD
Fesoterodine—Constipation—Galantamine—Alzheimer's disease	0.000645	0.00323	CcSEcCtD
Fesoterodine—Vertigo—Donepezil—Alzheimer's disease	0.000644	0.00322	CcSEcCtD
Fesoterodine—Flatulence—Memantine—Alzheimer's disease	0.000641	0.00321	CcSEcCtD
Fesoterodine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000641	0.00321	CcSEcCtD
Fesoterodine—Dysgeusia—Memantine—Alzheimer's disease	0.000637	0.00319	CcSEcCtD
Fesoterodine—Back pain—Memantine—Alzheimer's disease	0.000629	0.00315	CcSEcCtD
Fesoterodine—Flatulence—Rivastigmine—Alzheimer's disease	0.000627	0.00314	CcSEcCtD
Fesoterodine—Cough—Donepezil—Alzheimer's disease	0.000625	0.00313	CcSEcCtD
Fesoterodine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000623	0.00312	CcSEcCtD
Fesoterodine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000622	0.00311	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000617	0.00309	CcSEcCtD
Fesoterodine—Back pain—Rivastigmine—Alzheimer's disease	0.000616	0.00308	CcSEcCtD
Fesoterodine—Vision blurred—Memantine—Alzheimer's disease	0.000613	0.00307	CcSEcCtD
Fesoterodine—Chest pain—Donepezil—Alzheimer's disease	0.00061	0.00305	CcSEcCtD
Fesoterodine—Vision blurred—Rivastigmine—Alzheimer's disease	0.0006	0.003	CcSEcCtD
Fesoterodine—Dry mouth—Donepezil—Alzheimer's disease	0.000597	0.00299	CcSEcCtD
Fesoterodine—Abdominal pain—Galantamine—Alzheimer's disease	0.000597	0.00299	CcSEcCtD
Fesoterodine—CHRM2—nervous system—Alzheimer's disease	0.000593	0.0292	CbGeAlD
Fesoterodine—Confusional state—Donepezil—Alzheimer's disease	0.00059	0.00295	CcSEcCtD
Fesoterodine—Vertigo—Memantine—Alzheimer's disease	0.000585	0.00293	CcSEcCtD
Fesoterodine—Infection—Donepezil—Alzheimer's disease	0.000581	0.00291	CcSEcCtD
Fesoterodine—Palpitations—Memantine—Alzheimer's disease	0.000575	0.00288	CcSEcCtD
Fesoterodine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000574	0.00287	CcSEcCtD
Fesoterodine—Vertigo—Rivastigmine—Alzheimer's disease	0.000572	0.00286	CcSEcCtD
Fesoterodine—CHRM2—central nervous system—Alzheimer's disease	0.000571	0.0281	CbGeAlD
Fesoterodine—Cough—Memantine—Alzheimer's disease	0.000568	0.00284	CcSEcCtD
Fesoterodine—Palpitations—Rivastigmine—Alzheimer's disease	0.000562	0.00282	CcSEcCtD
Fesoterodine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000556	0.00278	CcSEcCtD
Fesoterodine—Cough—Rivastigmine—Alzheimer's disease	0.000555	0.00278	CcSEcCtD
Fesoterodine—Chest pain—Memantine—Alzheimer's disease	0.000554	0.00277	CcSEcCtD
Fesoterodine—Chest pain—Rivastigmine—Alzheimer's disease	0.000542	0.00271	CcSEcCtD
Fesoterodine—Dry mouth—Memantine—Alzheimer's disease	0.000542	0.00271	CcSEcCtD
Fesoterodine—Asthenia—Galantamine—Alzheimer's disease	0.000541	0.00271	CcSEcCtD
Fesoterodine—CHRM1—nervous system—Alzheimer's disease	0.00054	0.0266	CbGeAlD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000538	0.00269	CcSEcCtD
Fesoterodine—Confusional state—Memantine—Alzheimer's disease	0.000535	0.00268	CcSEcCtD
Fesoterodine—Dry mouth—Rivastigmine—Alzheimer's disease	0.00053	0.00265	CcSEcCtD
Fesoterodine—Insomnia—Donepezil—Alzheimer's disease	0.000529	0.00265	CcSEcCtD
Fesoterodine—Infection—Memantine—Alzheimer's disease	0.000528	0.00264	CcSEcCtD
Fesoterodine—Confusional state—Rivastigmine—Alzheimer's disease	0.000524	0.00262	CcSEcCtD
Fesoterodine—Nervous system disorder—Memantine—Alzheimer's disease	0.000521	0.00261	CcSEcCtD
Fesoterodine—Somnolence—Donepezil—Alzheimer's disease	0.00052	0.0026	CcSEcCtD
Fesoterodine—CHRM1—central nervous system—Alzheimer's disease	0.000519	0.0256	CbGeAlD
Fesoterodine—Tachycardia—Memantine—Alzheimer's disease	0.000518	0.00259	CcSEcCtD
Fesoterodine—Diarrhoea—Galantamine—Alzheimer's disease	0.000516	0.00258	CcSEcCtD
Fesoterodine—Infection—Rivastigmine—Alzheimer's disease	0.000516	0.00258	CcSEcCtD
Fesoterodine—Skin disorder—Memantine—Alzheimer's disease	0.000516	0.00258	CcSEcCtD
Fesoterodine—Dyspepsia—Donepezil—Alzheimer's disease	0.000515	0.00258	CcSEcCtD
Fesoterodine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000509	0.00255	CcSEcCtD
Fesoterodine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000507	0.00254	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000505	0.00253	CcSEcCtD
Fesoterodine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000505	0.00253	CcSEcCtD
Fesoterodine—Fatigue—Donepezil—Alzheimer's disease	0.000504	0.00252	CcSEcCtD
Fesoterodine—Constipation—Donepezil—Alzheimer's disease	0.0005	0.0025	CcSEcCtD
Fesoterodine—Dizziness—Galantamine—Alzheimer's disease	0.000499	0.0025	CcSEcCtD
Fesoterodine—CHRM3—nervous system—Alzheimer's disease	0.000483	0.0238	CbGeAlD
Fesoterodine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000482	0.00241	CcSEcCtD
Fesoterodine—CYP2D6—forebrain—Alzheimer's disease	0.000481	0.0237	CbGeAlD
Fesoterodine—Insomnia—Memantine—Alzheimer's disease	0.00048	0.0024	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000478	0.00239	CcSEcCtD
Fesoterodine—Rash—Galantamine—Alzheimer's disease	0.000476	0.00238	CcSEcCtD
Fesoterodine—Dermatitis—Galantamine—Alzheimer's disease	0.000475	0.00238	CcSEcCtD
Fesoterodine—Headache—Galantamine—Alzheimer's disease	0.000473	0.00237	CcSEcCtD
Fesoterodine—Somnolence—Memantine—Alzheimer's disease	0.000472	0.00236	CcSEcCtD
Fesoterodine—Insomnia—Rivastigmine—Alzheimer's disease	0.00047	0.00235	CcSEcCtD
Fesoterodine—Dyspepsia—Memantine—Alzheimer's disease	0.000467	0.00234	CcSEcCtD
Fesoterodine—CHRM3—central nervous system—Alzheimer's disease	0.000465	0.0229	CbGeAlD
Fesoterodine—Urticaria—Donepezil—Alzheimer's disease	0.000465	0.00233	CcSEcCtD
Fesoterodine—Abdominal pain—Donepezil—Alzheimer's disease	0.000462	0.00231	CcSEcCtD
Fesoterodine—Somnolence—Rivastigmine—Alzheimer's disease	0.000462	0.00231	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000458	0.00229	CcSEcCtD
Fesoterodine—Fatigue—Memantine—Alzheimer's disease	0.000458	0.00229	CcSEcCtD
Fesoterodine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000457	0.00229	CcSEcCtD
Fesoterodine—Constipation—Memantine—Alzheimer's disease	0.000454	0.00227	CcSEcCtD
Fesoterodine—CHRM2—brain—Alzheimer's disease	0.000453	0.0223	CbGeAlD
Fesoterodine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000448	0.00224	CcSEcCtD
Fesoterodine—Nausea—Galantamine—Alzheimer's disease	0.000448	0.00224	CcSEcCtD
Fesoterodine—Fatigue—Rivastigmine—Alzheimer's disease	0.000448	0.00224	CcSEcCtD
Fesoterodine—Constipation—Rivastigmine—Alzheimer's disease	0.000444	0.00222	CcSEcCtD
Fesoterodine—CYP2D6—telencephalon—Alzheimer's disease	0.000442	0.0218	CbGeAlD
Fesoterodine—Feeling abnormal—Memantine—Alzheimer's disease	0.000438	0.00219	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000434	0.00217	CcSEcCtD
Fesoterodine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000431	0.00216	CcSEcCtD
Fesoterodine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000428	0.00214	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000425	0.00213	CcSEcCtD
Fesoterodine—Urticaria—Memantine—Alzheimer's disease	0.000422	0.00211	CcSEcCtD
Fesoterodine—Abdominal pain—Memantine—Alzheimer's disease	0.00042	0.0021	CcSEcCtD
Fesoterodine—Asthenia—Donepezil—Alzheimer's disease	0.00042	0.0021	CcSEcCtD
Fesoterodine—Pruritus—Donepezil—Alzheimer's disease	0.000414	0.00207	CcSEcCtD
Fesoterodine—Urticaria—Rivastigmine—Alzheimer's disease	0.000413	0.00207	CcSEcCtD
Fesoterodine—CHRM1—brain—Alzheimer's disease	0.000412	0.0203	CbGeAlD
Fesoterodine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000411	0.00206	CcSEcCtD
Fesoterodine—Diarrhoea—Donepezil—Alzheimer's disease	0.0004	0.002	CcSEcCtD
Fesoterodine—Hypersensitivity—Memantine—Alzheimer's disease	0.000391	0.00196	CcSEcCtD
Fesoterodine—ABCB1—embryo—Alzheimer's disease	0.000391	0.0193	CbGeAlD
Fesoterodine—Dizziness—Donepezil—Alzheimer's disease	0.000387	0.00194	CcSEcCtD
Fesoterodine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000383	0.00192	CcSEcCtD
Fesoterodine—Asthenia—Memantine—Alzheimer's disease	0.000381	0.00191	CcSEcCtD
Fesoterodine—Pruritus—Memantine—Alzheimer's disease	0.000376	0.00188	CcSEcCtD
Fesoterodine—Asthenia—Rivastigmine—Alzheimer's disease	0.000373	0.00187	CcSEcCtD
Fesoterodine—CHRM3—brain—Alzheimer's disease	0.000369	0.0182	CbGeAlD
Fesoterodine—Rash—Donepezil—Alzheimer's disease	0.000369	0.00185	CcSEcCtD
Fesoterodine—Dermatitis—Donepezil—Alzheimer's disease	0.000368	0.00184	CcSEcCtD
Fesoterodine—Pruritus—Rivastigmine—Alzheimer's disease	0.000368	0.00184	CcSEcCtD
Fesoterodine—Headache—Donepezil—Alzheimer's disease	0.000366	0.00183	CcSEcCtD
Fesoterodine—Diarrhoea—Memantine—Alzheimer's disease	0.000363	0.00182	CcSEcCtD
Fesoterodine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000355	0.00178	CcSEcCtD
Fesoterodine—Dizziness—Memantine—Alzheimer's disease	0.000351	0.00176	CcSEcCtD
Fesoterodine—Nausea—Donepezil—Alzheimer's disease	0.000347	0.00174	CcSEcCtD
Fesoterodine—ABCB1—forebrain—Alzheimer's disease	0.000346	0.0171	CbGeAlD
Fesoterodine—Dizziness—Rivastigmine—Alzheimer's disease	0.000344	0.00172	CcSEcCtD
Fesoterodine—Rash—Memantine—Alzheimer's disease	0.000335	0.00168	CcSEcCtD
Fesoterodine—Dermatitis—Memantine—Alzheimer's disease	0.000334	0.00167	CcSEcCtD
Fesoterodine—Headache—Memantine—Alzheimer's disease	0.000333	0.00166	CcSEcCtD
Fesoterodine—Rash—Rivastigmine—Alzheimer's disease	0.000328	0.00164	CcSEcCtD
Fesoterodine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000327	0.00164	CcSEcCtD
Fesoterodine—Headache—Rivastigmine—Alzheimer's disease	0.000325	0.00163	CcSEcCtD
Fesoterodine—ABCB1—telencephalon—Alzheimer's disease	0.000318	0.0157	CbGeAlD
Fesoterodine—Nausea—Memantine—Alzheimer's disease	0.000315	0.00158	CcSEcCtD
Fesoterodine—Nausea—Rivastigmine—Alzheimer's disease	0.000309	0.00154	CcSEcCtD
Fesoterodine—CYP3A4—nervous system—Alzheimer's disease	0.000265	0.0131	CbGeAlD
Fesoterodine—CYP2D6—nervous system—Alzheimer's disease	0.000261	0.0129	CbGeAlD
Fesoterodine—CYP3A4—central nervous system—Alzheimer's disease	0.000255	0.0126	CbGeAlD
Fesoterodine—CYP2D6—central nervous system—Alzheimer's disease	0.000251	0.0124	CbGeAlD
Fesoterodine—CYP2D6—cerebellum—Alzheimer's disease	0.000246	0.0121	CbGeAlD
Fesoterodine—CYP2D6—brain—Alzheimer's disease	0.0002	0.00984	CbGeAlD
Fesoterodine—ABCB1—nervous system—Alzheimer's disease	0.000188	0.00926	CbGeAlD
Fesoterodine—ABCB1—central nervous system—Alzheimer's disease	0.000181	0.00891	CbGeAlD
Fesoterodine—ABCB1—cerebellum—Alzheimer's disease	0.000177	0.00871	CbGeAlD
Fesoterodine—ABCB1—brain—Alzheimer's disease	0.000144	0.00708	CbGeAlD
Fesoterodine—CHRM1—Signaling Pathways—APP—Alzheimer's disease	1.26e-05	0.000253	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—A2M—Alzheimer's disease	1.26e-05	0.000252	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.26e-05	0.000252	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APP—Alzheimer's disease	1.26e-05	0.000252	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PRKCG—Alzheimer's disease	1.25e-05	0.00025	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APP—Alzheimer's disease	1.24e-05	0.000249	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCR5—Alzheimer's disease	1.24e-05	0.000248	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.23e-05	0.000246	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NGF—Alzheimer's disease	1.22e-05	0.000244	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	1.21e-05	0.000243	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HTR2A—Alzheimer's disease	1.21e-05	0.000242	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	1.21e-05	0.000242	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	1.19e-05	0.000239	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	1.19e-05	0.000238	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	1.19e-05	0.000238	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.19e-05	0.000238	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	1.18e-05	0.000237	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCR5—Alzheimer's disease	1.18e-05	0.000237	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—HMOX1—Alzheimer's disease	1.18e-05	0.000236	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	1.17e-05	0.000235	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HTR2A—Alzheimer's disease	1.16e-05	0.000232	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CALM1—Alzheimer's disease	1.13e-05	0.000226	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—LEP—Alzheimer's disease	1.12e-05	0.000225	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—APOE—Alzheimer's disease	1.12e-05	0.000225	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CAV1—Alzheimer's disease	1.11e-05	0.000223	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	1.11e-05	0.000222	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	1.11e-05	0.000222	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	1.1e-05	0.000221	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	1.1e-05	0.00022	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	1.09e-05	0.000219	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.09e-05	0.000219	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	1.09e-05	0.000218	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	1.08e-05	0.000217	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.08e-05	0.000217	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CALM1—Alzheimer's disease	1.08e-05	0.000217	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	1.08e-05	0.000216	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	1.08e-05	0.000216	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—LPL—Alzheimer's disease	1.08e-05	0.000216	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—APOE—Alzheimer's disease	1.08e-05	0.000216	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—LEP—Alzheimer's disease	1.08e-05	0.000216	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	1.08e-05	0.000216	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ESR1—Alzheimer's disease	1.07e-05	0.000215	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	1.07e-05	0.000214	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CAV1—Alzheimer's disease	1.07e-05	0.000214	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	1.06e-05	0.000213	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.06e-05	0.000213	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—F2—Alzheimer's disease	1.06e-05	0.000213	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NOTCH1—Alzheimer's disease	1.04e-05	0.000208	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	1.03e-05	0.000207	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ESR1—Alzheimer's disease	1.03e-05	0.000206	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.03e-05	0.000205	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.03e-05	0.000205	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	1.02e-05	0.000205	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	1.02e-05	0.000205	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	1.02e-05	0.000204	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—F2—Alzheimer's disease	1.02e-05	0.000204	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	1.01e-05	0.000203	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.01e-05	0.000202	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOTCH1—Alzheimer's disease	9.93e-06	0.000199	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	9.76e-06	0.000196	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—GSK3B—Alzheimer's disease	9.74e-06	0.000195	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	9.72e-06	0.000195	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—MTHFR—Alzheimer's disease	9.71e-06	0.000195	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	9.66e-06	0.000194	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	9.66e-06	0.000194	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CREB1—Alzheimer's disease	9.66e-06	0.000194	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	9.63e-06	0.000193	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—INS—Alzheimer's disease	9.6e-06	0.000193	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—BCHE—Alzheimer's disease	9.53e-06	0.000191	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCL2—Alzheimer's disease	9.45e-06	0.000189	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	9.43e-06	0.000189	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	9.4e-06	0.000188	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—GSK3B—Alzheimer's disease	9.32e-06	0.000187	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	9.31e-06	0.000187	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IGF1—Alzheimer's disease	9.29e-06	0.000186	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CREB1—Alzheimer's disease	9.25e-06	0.000185	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—INS—Alzheimer's disease	9.2e-06	0.000184	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CALM1—Alzheimer's disease	9.07e-06	0.000182	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCL2—Alzheimer's disease	9.05e-06	0.000181	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	9.04e-06	0.000181	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—APOE—Alzheimer's disease	9.04e-06	0.000181	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	9.01e-06	0.000181	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	8.99e-06	0.00018	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	8.98e-06	0.00018	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	8.96e-06	0.00018	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CAV1—Alzheimer's disease	8.95e-06	0.000179	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	8.93e-06	0.000179	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	8.93e-06	0.000179	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IGF1—Alzheimer's disease	8.9e-06	0.000178	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	8.85e-06	0.000177	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	8.79e-06	0.000176	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	8.76e-06	0.000176	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	8.72e-06	0.000175	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	8.69e-06	0.000174	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	8.69e-06	0.000174	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	8.68e-06	0.000174	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	8.56e-06	0.000172	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	8.54e-06	0.000171	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	8.47e-06	0.00017	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	8.45e-06	0.000169	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NOS3—Alzheimer's disease	8.42e-06	0.000169	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	8.33e-06	0.000167	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	8.33e-06	0.000167	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	8.3e-06	0.000166	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	8.22e-06	0.000165	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	8.21e-06	0.000165	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	8.15e-06	0.000163	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	8.13e-06	0.000163	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOS3—Alzheimer's disease	8.06e-06	0.000162	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	8.05e-06	0.000161	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	8.02e-06	0.000161	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PPARG—Alzheimer's disease	7.87e-06	0.000158	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—A2M—Alzheimer's disease	7.75e-06	0.000155	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—INS—Alzheimer's disease	7.72e-06	0.000155	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	7.61e-06	0.000152	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	7.58e-06	0.000152	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	7.58e-06	0.000152	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	7.58e-06	0.000152	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	7.56e-06	0.000151	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	7.56e-06	0.000151	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	7.51e-06	0.000151	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	7.51e-06	0.000151	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	7.51e-06	0.000151	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	7.49e-06	0.00015	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	7.48e-06	0.00015	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	7.48e-06	0.00015	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	7.48e-06	0.00015	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	7.41e-06	0.000149	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	7.24e-06	0.000145	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—AKT1—Alzheimer's disease	7.22e-06	0.000145	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	7.21e-06	0.000145	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CASP3—Alzheimer's disease	7.15e-06	0.000143	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—F2—Alzheimer's disease	7.15e-06	0.000143	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	7.14e-06	0.000143	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—F2—Alzheimer's disease	7.13e-06	0.000143	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6—Alzheimer's disease	7.1e-06	0.000142	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	7.08e-06	0.000142	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	7.06e-06	0.000141	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	7.05e-06	0.000141	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	7e-06	0.00014	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	6.97e-06	0.00014	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—AKT1—Alzheimer's disease	6.91e-06	0.000139	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	6.91e-06	0.000138	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CASP3—Alzheimer's disease	6.85e-06	0.000137	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—LPL—Alzheimer's disease	6.84e-06	0.000137	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6—Alzheimer's disease	6.8e-06	0.000136	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—NOS3—Alzheimer's disease	6.77e-06	0.000136	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	6.74e-06	0.000135	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	6.66e-06	0.000134	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	6.57e-06	0.000132	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	6.56e-06	0.000132	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	6.55e-06	0.000131	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	6.54e-06	0.000131	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	6.51e-06	0.000131	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	6.49e-06	0.00013	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	6.48e-06	0.00013	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	6.48e-06	0.00013	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—INS—Alzheimer's disease	6.45e-06	0.000129	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—LPL—Alzheimer's disease	6.45e-06	0.000129	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	6.43e-06	0.000129	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	6.39e-06	0.000128	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	6.37e-06	0.000128	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	6.35e-06	0.000127	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	6.32e-06	0.000127	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	6.32e-06	0.000127	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	6.29e-06	0.000126	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	6.29e-06	0.000126	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	6.28e-06	0.000126	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	6.26e-06	0.000126	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	6.24e-06	0.000125	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	6.19e-06	0.000124	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS2—Alzheimer's disease	6.19e-06	0.000124	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	6.18e-06	0.000124	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	6.16e-06	0.000123	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	6.07e-06	0.000122	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.87e-06	0.000118	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	5.81e-06	0.000116	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	5.8e-06	0.000116	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CALM1—Alzheimer's disease	5.75e-06	0.000115	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOE—Alzheimer's disease	5.73e-06	0.000115	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CAV1—Alzheimer's disease	5.68e-06	0.000114	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	5.68e-06	0.000114	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	5.66e-06	0.000113	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	5.61e-06	0.000112	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	5.57e-06	0.000112	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	5.54e-06	0.000111	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	5.42e-06	0.000109	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOE—Alzheimer's disease	5.4e-06	0.000108	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	5.37e-06	0.000108	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	5.35e-06	0.000107	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	5.33e-06	0.000107	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARG—Alzheimer's disease	4.99e-06	0.0001	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—INS—Alzheimer's disease	4.9e-06	9.82e-05	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.87e-06	9.75e-05	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	4.85e-06	9.72e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	4.82e-06	9.66e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	4.81e-06	9.63e-05	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.8e-06	9.63e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	4.79e-06	9.6e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	4.77e-06	9.57e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	4.76e-06	9.54e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	4.73e-06	9.48e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	4.71e-06	9.43e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.63e-06	9.28e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—INS—Alzheimer's disease	4.62e-06	9.25e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.61e-06	9.24e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	4.58e-06	9.19e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	4.43e-06	8.88e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	4.42e-06	8.86e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	4.42e-06	8.85e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	4.4e-06	8.83e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	4.39e-06	8.8e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	4.37e-06	8.77e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	4.36e-06	8.74e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NOS3—Alzheimer's disease	4.3e-06	8.61e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—LPL—Alzheimer's disease	4.21e-06	8.45e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	4.2e-06	8.41e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	4.09e-06	8.2e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	4.08e-06	8.17e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	4.05e-06	8.11e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	4.04e-06	8.1e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	4.02e-06	8.06e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	3.93e-06	7.88e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	3.87e-06	7.76e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.79e-06	7.61e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	3.75e-06	7.53e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	3.74e-06	7.5e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	3.71e-06	7.43e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	3.71e-06	7.43e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.7e-06	7.42e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.54e-06	7.11e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.53e-06	7.08e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.5e-06	7.02e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—AKT1—Alzheimer's disease	3.11e-06	6.24e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	3.09e-06	6.2e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	3.08e-06	6.18e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.08e-06	6.17e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	3.05e-06	6.12e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—INS—Alzheimer's disease	3.02e-06	6.05e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	2.83e-06	5.67e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	2.82e-06	5.65e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	2.79e-06	5.6e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.65e-06	5.3e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	2.61e-06	5.23e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	2.6e-06	5.22e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	2.58e-06	5.17e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.42e-06	4.85e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.97e-06	3.96e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.86e-06	3.73e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.22e-06	2.44e-05	CbGpPWpGaD
